Evidence-based neonatal medicine in Latin America: what can we learn from the International Neonatal Immunotherapy Study and trials of IVIg?

Although reliable randomized trials are essential to guide policy and avoid unnecessary expenditure on ineffective treatments, very few babies or pregnant women in Latin America, and in the rest of the world, are recruited into multicenter perinatal trials. Three strategies to address this are (i) to establish clinical research networks for perinatal trials, (ii) to provide
hospitals with funding to publish
the numbers of patients recruited
in multicenter perinatal trials as an
indicator of performance, and (iii) to
engage parents as full partners in, and
advocates for, perinatal trials.

See full article: https://www.miraclebabies.org.au/media/1039/tarnow-mordi-cruz-j-pediatria-2012.pdf